This consideration is compatible with the findings again reported by Adams et al. [42], who demonstrated that triple negative breast cancer cells - when exposed to PROTAC - show elevated p73 that takes over the tumor suppressor activity of an inactive p53. This evidence concerns the gene TP53 and triple-negative breast carcinoma.